We aimed to examine whether in vivo CAV1 expression is associated with MetS; therefore, we evaluated the mRNA and protein levels of CAV1 in subcutaneous ATs isolated from 38 individuals with differing MetS scores (siMS). This evidence concerns the gene CAV1 and metabolic syndrome.